| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-56 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-56 |
| filingDate |
2003-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25c71142e9951f0cd1fc582c93da046d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5510e73225513246bf4e4a6778d967a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ba857fb38815b7ab04fba6f44e75630 |
| publicationDate |
2005-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005032142-A1 |
| titleOfInvention |
Protocol and apparatus for determining heparin-induced thrombocytopenia |
| abstract |
A hemostasis analyzer, such as the Thrombelastograph® (TEG®) hemostasis analyzer is utilized to measure continuously in real time, the hemostasis process from the initial fibrin formation, through platelet-fibrin interaction and lysis to generate blood hemostasis parameters. The measured blood hemostasis parameters permit determination of heparin-induced thrombocytopenia II complex (HiT II). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008038828-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021217154-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8008086-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013013043-A1 |
| priorityDate |
2003-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |